
Enterprising architect merges passion
of architecture with love of
science to become a recognized
leader in the area of research
facility design.
Recently, Ken sat down with Dana
Tennis of RetirementDNA to
discuss a wide range of topics – the
life sciences and architecture,
worldwide biotech trends, the status
of high school science education,
and what
it was like to grow up with a Nobel
Laureate as a father.
Q:1 Ken,
tell us a little bit about
your background?
How did you end up starting
your company here in San
Diego and San Francisco?
I
was born in Bethesda, MD, where
both of my parents were scientists
at the NIH. We moved to St.
Louis where we stayed for 6 years
before
moving to the SF Bay
area in 1959. With both parents being scientists, I felt very at home in a
lab—as
familiar as a kitchen is to most children. Once a month the entire biochemistry
department gathered at our home to party and discuss their work. I grew up
surrounded by science and scientists;
my two brothers became scientists
as well.
In 1967,
at the age of 17, I spent a summer
working
in a marine biology lab
at the Scripps Institution of Oceanography. As part of my research, I was
given the use of a surfer’s “woody” station
wagon, and asked to search the
beaches for new species of diatom.
That summer I met Junior Miss
La Jolla,
discovered a new diatom, and developed a lifelong love of the ocean. I thought
science was great.
When I enrolled
at Stanford I assumed I would
be a
music or marine biology
major, but it wasn’t long before I was lured away by the beautiful
drawings and models I saw in the architecture department.
I started
my working career in Bay Area
architecture firms designing
houses, department
stores and junior colleges. I met my wife, Veronica (we are
now married 26 years-and have three daughters 15, 21 and 23), at a firm
in San
Francisco.
We moved to Del Mar where Veronica enrolled at UCSD. I was very happy
to return to La Jolla. I opened
my first office in Del Mar in
the Tudor building
at Camino
del Mar and 15th Street with a view of the ocean. My first project was
a lab remodel in the Stanford Genetics Department for a friend I met
that summer
in 1967 in La Jolla. That project was completed in 1980, when the biotech
industry
was just taking off in San Diego and the Bay Area. That first biomedical
research project at Stanford led to several projects in La Jolla, at
Cal Tech, Stanford,
and UCSF. I opened an office in Menlo Park in 1986 when we received several
larger
commissions there and moved back to the Bay Area around that time. Since
then Kornberg Assoc. has completed 400 biomedical research projects on
4 continents.
In addition to the offices in MP and SD, we have a third office in Tokyo
Q:2 Tell
us about Kornberg Associates
and how you came to focus on
the Life Science and Biotech
arena.
As an architect
I was unusually knowledgeable
about
how labs
worked. The coupling of that
knowledge and my interest
in fun design turned out
to
be unusual among
architects. My detailed understanding of the research environment
produced both a technical and
humane nature to the lab designs
that many scientists
enjoy.
Q:3 What
is the process you go through
when trying to get to know a
client's design needs
and wants?
The major factors we start
with are: 1) the scope of the
project: that is what they
hope to do when the project
is complete 2) the
schedule
of the
project
and 3) the funds available to do the project. Once we determine
the balance of these
factors we look at the long term and immediate demands of the facility
and check that the design is comprehensive. We do a lot of 3D modeling
and often
use examples
of our facilities to help our clients understand the different
options and new solutions that
might be effective for them.
Q:4 You’re doing
business all over the world
these days. Tell us about the
global biotech market.
Though it is clear that the biotech industry has a promising future,
at present the US venture capital for biotech is at a low, particularly
for
any funding
before Phase three. The governments of many cities and countries
are eager to become major players in the biotech industry. However,
most
don’t have
even one biotech company, let alone a university with a brain trust
that can support an industry. Singapore stands out for having developed
a remarkable core
of fine researchers in a small island and an economic environment
to fuel a successful industry. Their timing was perfect for the
abandonment of stem cell research
in the US, and they were instantly able to attract scientists from
the US who were unable to get federal support here for their research.
The venture capital
market in Europe and Asia is no more robust than in the US. Currently,
all Kornberg Associates overseas work is with universities,
pharmaceutical or major private
medical institutions.
Q:5 What differences -economic or regulatory- are you seeing in
foreign countries compared to the US?
The regulatory differences vary based on location, but all labs
depend on either the USFDA or an equivalent if they have a procedure
or
product that
will need
market approval. The FDA is considered a world standard. Japan
and Europe have their own versions. The Japanese standards are
generally
considered
more rigid
than the US FDA and all the international regulatory agencies keep
a very close look on what the others are doing. Our project in
Dubai is
seeking
US FDA validation,
even though there is no government requirement for it.
Q:6 Are there any Prop 71 type funding scenarios overseas
that you’re aware
of?
Yes, the Singapore, French, British, South Korean and other governments
are funding stem cell research.
Q:7 If you were Governor for one month and had unilateral authority
to make changes that would stick, what would be your top three
initiatives?
-
Provide free health care for the needy.
- Make California the number one state in
public education.
- Provide economic incentives for small business and start-ups.
Q:8 Have high school labs
kept pace with biotech and life science developments?
No. Biotech was invented in California just at the time California
plummeted from Number 1 in the country to number 49 in public education.
California
universities, private research institutions and biotech campuses
conduct some of the best
life science research in the world, but any tour of the high school
labs will show
why California students do not score well on national exams. I
had very good high school science courses in my local public school
in
the San
Francisco Bay Area. We did not have honors courses then. Now only
a few honors programs
at
a few select schools have respectable programs for science education.
Q:9 Do you believe we need to be doing more at the high school
level to encourage a passion for science? If so, what?
Yes. Curiosity is the basis of passion for science, but it needs
to be nurtured and propagated by enthusiastic teachers. Teachers
with
poor
labs, poor texts,
and classes that are too large for them to work effectively soon
lose their enthusiasm and ability to fuel the passion. Our teachers
need
to be supported
in their classroom
work and in their own professional development.
Q10: What was it like to grow up with a Nobel Laureate for a father?
It was awesome, dude.
Q11: Do you ever think about the irony of your career in
that one of the labs you’ve designed may be housing a future
Nobel winner like your father?
One of the first labs I designed was for Harold Varmus who received
the prize in medicine for his work on oncogenes several years after
we designed
his
lab. I enjoyed working with Harold because he cared so much about
creating an enduring
and fun environment for his research group.
Q:12 Who are your favorite
architects from past or present, and why?
My favorite architect is Frank Lloyd Wright. His design work is
so well scaled to the person and the human experience and he was
such
a fine
artist. Another
20th Century architect I like is Antonio Gaudi. His playful, energetic
forms are so easy to enjoy. Eero Saarinen was another remarkable
20th C. architect
with an exquisite talent for creating exhilarating building forms.
Among contemporary architects, Santiago Calatrava is among the
most exciting
in his expression
of structure in architectural form . Other contemporary architects
who I find consistently
exciting and inspiring are Tadao Ando and Renzo Piano. I have been
fortunate to work with two luminaries: Cesar Pelli and I.M. Pei.
Working with them
and experiencing their wisdom and creative energies has been enlightening
and inspiring
for me.
Q:13 Favorite place to get away and think?
I love to go to the mountains or the beach, but I find my best
thoughts often come when I am running which I do in the hills near
my home.
Q:14 When you and your wife want to escape for a romantic dinner
here in town, where is your favorite place?
We love AR Valentien for its beautiful views, consistently fine
food, intimate seating and it is quiet.
Q:15 OK, time for our classic question. What is the Kornberg signature
dish to prepare? What wine would you pour and what music would
be playing in the
background?
The chocolate mousse from Piret’s cookbook. Well, okay, if we must have
an entree with our dessert, how about foie gras with caramelized apples and a
duck reduction sauce and a bottle of sauterne? (Followed by a small jar of Lipitor.)
This may not be our signature dish, but we did make it for New Year’s Eve
last year. I would start with a Bach Partita but soon enough Veronica would replace
it with Tito Puente.
Thanks,
Ken.
INTERVIEWS
FROM SPOTLIGHT ON SCIENCE |
Joseph Panetta,
Chief Executive Officer,
BIOCOM |
Al Kern, Ph.D., Cal State
University, San Marcos |
Ken Kornberg, President, Kornberg Associates |
Duane Roth, Chief Executive Officer, CONNECT |
Corrina
Herrnstadt, Principal & Senior
VP, Navica Partners |
| Kleanthis G. Xanthropoulos, Ph.D., Managing Director, Enterprise Partners |
| Lisa Haile, J.D., Ph.D., Partner Co-Chair, Life Sciences Practice Group, DLA Piper US LLP |
Pam
Gardner, President &
CEO, Biotech Vendor Services
Inc. |
|
Ian Wisenberg, Senior VP Business Development & CFO,
BIOCOM
|
|